By Benjamin Chiou
Date: Monday 12 Jan 2026
(Sharecast News) - Shares in Nasdaq-listed Abivax soared in pre-market trading on Monday after reports emerged that pharma giant Eli Lilly was preparing a $17.5bn bid for the Paris-based biotech firm.
| Currency | US Dollars |
| Share Price | $ 1,032.97 |
| Change Today | $ -40.32 |
| % Change | -3.76 % |
| 52 Week High | $1,109.94 |
| 52 Week Low | $625.65 |
| Volume | 4,183,400 |
| Shares Issued | 948.17m |
| Market Cap | $979,431m |
| Beta | 0.02 |
| RiskGrade | 179 |
| Time | Volume / Share Price |
| 15:59 | 80 @ $1,032.79 |
| 15:59 | 40 @ $1,032.66 |
| 15:59 | 40 @ $1,032.76 |
| 15:59 | 75 @ $1,032.66 |
| 15:59 | 43 @ $1,032.66 |
You are here: research